Substituted oxazolo[3,4-a]pyrazines as pharmaceutcals

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9359378
APP PUB NO 20150239903A1
SERIAL NO

14630410

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to novel derivatives of 6,7-dihydro-3H-oxazolo[3,4-a]pyrazine-5,8-dione represented by formula (I):

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BIOLAB SANUS FARMACEUTICA LTDABRAZIL ST PAUL SAO PAULO SAO PAULO

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Da, Costa Touzarim Carlos Eduardo São Paulo, BR 2 0
De, Sousa Bruno Artur São Paulo, BR 1 0
Sacurai, Sérgio Luiz São Paulo, BR 4 1
Toledo, Fabiano Travanca Osasco, BR 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 7, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00